Abstract:The cholinergic hypothesis has long been a “polar star” in drug discovery for Alzheimer’s disease (AD), resulting in many small molecules and biological drug candidates. Most of the drugs marketed for AD are cholinergic. Herein, we report our efforts in the discovery of cholinesterases inhibitors (ChEIs) as multi-target-directed ligands. A series of tacrine-ferulic acid hybrids have been designed and synthesised. All these compounds showed potent acetyl-(AChE) and butyryl cholinesterase(BuChE) inhibition. Among them, the optimal compound 10g, was the most potent inhibitor against AChE (electrophorus electricus (eeAChE) half maximal inhibitory concentration (IC50) = 37.02 nM), it was also a strong inhibitor against BuChE (equine serum (eqBuChE) IC50 = 101.40 nM). Besides, it inhibited amyloid β-protein self-aggregation by 65.49% at 25 μM. In subsequent in vivo scopolamine-induced AD models, compound 10g obviously ameliorated the cognition impairment and showed preliminary safety in hepatotoxicity evaluation. These data suggest compound 10g as a promising multifunctional agent in the drug discovery process against AD.

Inhibition of Cholinesterase Activity and Amyloid Aggregation by Berberine-Phenyl-benzoheterocyclic and Tacrine-Phenyl-benzoheterocyclic Hybrids.

Design, Synthesis and Evaluation of Novel Tacrine-Multialkoxybenzene Hybrids As Dual Inhibitors for Cholinesterases and Amyloid Beta Aggregation

Synthesis, Pharmacology and Molecular Docking on Multifunctional Tacrine-Ferulic Acid Hybrids As Cholinesterase Inhibitors Against Alzheimer's Disease

Design, Synthesis and Evaluation of Novel Tacrine Coumarin Hybrids As Multifunctional Cholinesterase Inhibitors Against Alzheimer'S Disease

Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Synthesis and Biological Evaluation of Berberine–thiophenyl Hybrids As Multi-Functional Agents: Inhibition of Acetylcholinesterase, Butyrylcholinesterase, and Aβ Aggregation and Antioxidant Activity

Syntheses of Coumarin–tacrine Hybrids As Dual-Site Acetylcholinesterase Inhibitors and Their Activity Against Butylcholinesterase, Aβ Aggregation, and Β-Secretase

Benzenediol-berberine Hybrids: Multifunctional Agents for Alzheimer's Disease.

Multi-target Tacrine-Coumarin Hybrids: Cholinesterase and Monoamine Oxidase B Inhibition Properties Against Alzheimer's Disease.

Design, Synthesis and Evaluation of Novel Tacrine-Rhein Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.

Design, Synthesis and Evaluation of Rivastigmine and Curcumin Hybrids As Site-Activated Multitarget-Directed Ligands for Alzheimer's Disease Therapy.

Synthesis and Activity Towards Alzheimer's Disease in Vitro: Tacrine, Phenolic Acid and Ligustrazine Hybrids.

Synthesis and Evaluation of Heterobivalent Tacrine Derivatives As Potential Multi-Functional Anti-Alzheimer Agents

Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors

Inhibition of Cholinesterase and Monoamine Oxidase-B Activity by Tacrine-Homoisoflavonoid Hybrids.

Design, Synthesis and Biological Evaluation of Multifunctional Tacrine-Curcumin Hybrids As New Cholinesterase Inhibitors with Metal Ions-Chelating and Neuroprotective Property

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.

Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids As Multifunctional Drug Candidates Against Alzheimer’s Disease